Ionis Pharmaceuticals filed institutional investment disclosures and received analyst rating coverage on August 30, 2026.
1 report, 1 independent
Updated Aug 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ionis Pharmaceuticals filed institutional investment disclosures and received analyst rating coverage on August 30, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Royal Bank of Canada
financial institution in Canada
Related events
- Applied Materials filed institutional holdings disclosures with the SEC and subsequently received an increased price target and rating.
- A company filed disclosures with the SEC, and a bank subsequently issued rating and price targets.
- Royal Bank of Canada filed with the Securities and Exchange Commission regarding institutional ownership disclosures on May 28, 2026.
- Pacira BioSciences, Inc. made company filings with the SEC and an analyst raised the stock rating on August 18, 2026.
- Analyst ratings disclosed via SEC filing involving Morgan Stanley, Royal Bank of Canada, and the SEC.